GlassScriptPhysician profile
Kenneth Vanowen
NPI 1053447250
$6,335.08
in general payments reported to CMS, 2019-2025
51 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $1,066 · 2021: $222 · 2022: $86.91 · 2023: $1,252 · 2024: $997 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,734.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $872.67 | 2019-2025 | Botox, Qulipta, Ubrelvy |
| Biogen, INC. | $722.23 | 2019-2025 | Tysabri, Vumerity |
| Inspire Medical Systems, INC. | $445.99 | 2023-2025 | Inspire |
| Pfizer INC. | $427.70 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $337.85 | 2019-2025 | |
| Amgen INC. | $309.69 | 2019-2021 | |
| Emd Serono, INC. | $269.48 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $218.97 | 2019-2025 | Ultomiris |
| Ucb, INC. | $215.31 | 2019-2025 | Rystiggo, Briviact |
| Allergan, INC. | $196.66 | 2019-2021 | |
| Lundbeck LLC | $194.89 | 2019-2025 | Vyepti, Rexulti |
| Harmony Biosciences LLC | $186.56 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $114.05 | 2019-2023 | |
| Ani Pharmaceuticals, INC. | $108.18 | 2025 | Purified Cortrophin Gel |
| Otsuka America Pharmaceutical, INC. | $101.04 | 2024-2025 | Rexulti |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Vanowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.